{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T03:18:12Z","timestamp":1771039092532,"version":"3.50.1"},"reference-count":18,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T00:00:00Z","timestamp":1673395200000},"content-version":"vor","delay-in-days":1716,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["mp.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Modern Pathology"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1038\/modpathol.2017.190","type":"journal-article","created":{"date-parts":[[2018,1,12]],"date-time":"2018-01-12T07:40:36Z","timestamp":1515742836000},"page":"809-815","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Glypican-1 immunohistochemistry is a novel marker to differentiate epithelioid mesothelioma from lung adenocarcinoma"],"prefix":"10.1016","volume":"31","author":[{"given":"Vishwa Jeet","family":"Amatya","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kei","family":"Kushitani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuichiro","family":"Kai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihiro","family":"Miyata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Morihito","family":"Okada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukio","family":"Takeshima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1038\/modpathol.2017.190_bib1","doi-asserted-by":"crossref","first-page":"716","DOI":"10.2471\/BLT.11.086678","article-title":"Global mesothelioma deaths reported to the World Health Organization between 1994 and 2008","volume":"89","author":"Delgermaa","year":"2011","journal-title":"Bull World Health Organ"},{"key":"10.1038\/modpathol.2017.190_bib2","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1046\/j.1365-2559.2003.01674.x","article-title":"'Pseudomesotheliomatous' carcinomas of the pleura: a 10-year analysis of cases from the Environmental Lung Disease Research Group, Cardiff","volume":"43","author":"Attanoos","year":"2003","journal-title":"Histopathology"},{"key":"10.1038\/modpathol.2017.190_bib3","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.jtho.2015.11.005","article-title":"World Health Organization Committee for Tumors of the P. The 2015 World Health Organization Classification of Tumors of the Pleura: advances since the 2004 classification","volume":"11","author":"Galateau-Salle","year":"2016","journal-title":"J Thorac Oncol"},{"key":"10.1038\/modpathol.2017.190_bib4","unstructured":"Husain AN, Colby TV, Ordonez NG et al. Guidelines for pathologic diagnosis of malignant mesothelioma: 2017 Update of the Consensus Statement From the International Mesothelioma Interest Group. Arch Pathol Lab Med 2017, 10.5858\/arpa.2017-0124-RA."},{"key":"10.1038\/modpathol.2017.190_bib5","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1097\/PAS.0000000000000852","article-title":"Identification of DAB2 and intelectin-1 as novel positive immunohistochemical markers of epithelioid mesothelioma by transcriptome microarray analysis for its differentiation from pulmonary adenocarcinoma","volume":"41","author":"Kuraoka","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/modpathol.2017.190_bib6","doi-asserted-by":"crossref","first-page":"647","DOI":"10.5858\/arpa.2012-0214-OA","article-title":"Guidelines for pathologic diagnosis of malignant mesothelioma: 2012 Update of the Consensus Statement from the International Mesothelioma Interest Group","volume":"137","author":"Husain","year":"2013","journal-title":"Arch Pathol Lab Med"},{"key":"10.1038\/modpathol.2017.190_bib7","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1097\/JTO.0000000000000630","article-title":"The 2015 World Health Organization Classification of Lung Tumors: impact of genetic, clinical and radiologic advances since the 2004 classification","volume":"10","author":"Travis","year":"2015","journal-title":"J Thorac Oncol"},{"key":"10.1038\/modpathol.2017.190_bib8","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1002\/bies.20612","article-title":"Proteoglycans: key partners in bone cell biology","volume":"29","author":"Lamoureux","year":"2007","journal-title":"BioEssays"},{"key":"10.1038\/modpathol.2017.190_bib9","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/sj.onc.1203322","article-title":"Expression of GPC3, an X-linked recessive overgrowth gene, is silenced in malignant mesothelioma","volume":"19","author":"Murthy","year":"2000","journal-title":"Oncogene"},{"key":"10.1038\/modpathol.2017.190_bib10","first-page":"5562","article-title":"Glypican-1 is overexpressed in human breast cancer and modulates the mitogenic effects of multiple heparin-binding growth factors in breast cancer cells","volume":"61","author":"Matsuda","year":"2001","journal-title":"Cancer Res"},{"key":"10.1038\/modpathol.2017.190_bib11","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1172\/JCI4105","article-title":"The cell-surface heparan sulfate proteoglycan glypican-1 regulates growth factor action in pancreatic carcinoma cells and is overexpressed in human pancreatic cancer","volume":"102","author":"Kleeff","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1038\/modpathol.2017.190_bib12","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/bjc.2016.183","article-title":"Overexpression of glypican-1 implicates poor prognosis and their chemoresistance in oesophageal squamous cell carcinoma","volume":"115","author":"Hara","year":"2016","journal-title":"Br J Cancer"},{"key":"10.1038\/modpathol.2017.190_bib13","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.2353\/ajpath.2006.050800","article-title":"Glypican-1 is frequently overexpressed in human gliomas and enhances FGF-2 signaling in glioma cells","volume":"168","author":"Su","year":"2006","journal-title":"Am J Pathol"},{"key":"10.1038\/modpathol.2017.190_bib14","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1126\/science.aan2507","article-title":"A pathology atlas of the human cancer transcriptome","volume":"357","author":"Uhlen","year":"2017","journal-title":"Science"},{"key":"10.1038\/modpathol.2017.190_bib15","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1172\/JCI32412","article-title":"Glypican-1 modulates the angiogenic and metastatic potential of human and mouse cancer cells","volume":"118","author":"Aikawa","year":"2008","journal-title":"J Clin Invest"},{"key":"10.1038\/modpathol.2017.190_bib16","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.asjsur.2012.08.001","article-title":"GPC-1 may serve as a predictor of perineural invasion and a prognosticator of survival in pancreatic cancer","volume":"36","author":"Duan","year":"2013","journal-title":"Asian J Surg"},{"key":"10.1038\/modpathol.2017.190_bib17","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/nature14581","article-title":"Glypican-1 identifies cancer exosomes and detects early pancreatic cancer","volume":"523","author":"Melo","year":"2015","journal-title":"Nature"},{"key":"10.1038\/modpathol.2017.190_bib18","doi-asserted-by":"crossref","first-page":"24741","DOI":"10.18632\/oncotarget.15799","article-title":"Glypican-1 targeted antibody-based therapy induces preclinical antitumor activity against esophageal squamous cell carcinoma","volume":"8","author":"Harada","year":"2017","journal-title":"Oncotarget"}],"container-title":["Modern Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/modpathol2017190.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/modpathol2017190","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222015137?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222015137?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/modpathol.2017.190","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/www.nature.com\/articles\/modpathol2017190.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T00:49:41Z","timestamp":1760230181000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0893395222015137"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":18,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["S0893395222015137"],"URL":"https:\/\/doi.org\/10.1038\/modpathol.2017.190","relation":{},"ISSN":["0893-3952"],"issn-type":[{"value":"0893-3952","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Glypican-1 immunohistochemistry is a novel marker to differentiate epithelioid mesothelioma from lung adenocarcinoma","name":"articletitle","label":"Article Title"},{"value":"Modern Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/modpathol.2017.190","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 United States & Canadian Academy of Pathology.","name":"copyright","label":"Copyright"}]}}